Genomic BCR-ABL1 Breakpoint Characterization by a Multi-Strategy Approach for �personalized Monitoring� of Residual Disease in Chronic Myeloid Leukemia Patients

Oncotarget - United States
doi 10.18632/oncotarget.23971

Related search